000 | 01900 a2200529 4500 | ||
---|---|---|---|
005 | 20250514161304.0 | ||
264 | 0 | _c20040112 | |
008 | 200401s 0 0 fre d | ||
022 | _a0181-5512 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBensoussan, L | |
245 | 0 | 0 |
_a[Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments]. _h[electronic resource] |
260 |
_bJournal francais d'ophtalmologie _cOct 2003 |
||
300 |
_a782-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; English Abstract; Journal Article | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aBenzalkonium Compounds _xpharmacology |
650 | 0 | 4 |
_aCarbonic Anhydrase Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aConjunctiva _xcytology |
650 | 0 | 4 | _aCytological Techniques |
650 | 0 | 4 | _aCytoplasm |
650 | 0 | 4 | _aData Interpretation, Statistical |
650 | 0 | 4 |
_aEpithelial Cells _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aFluorescent Antibody Technique, Direct |
650 | 0 | 4 | _aFluorescent Antibody Technique, Indirect |
650 | 0 | 4 |
_aGlaucoma _xdrug therapy |
650 | 0 | 4 | _aGlaucoma, Open-Angle |
650 | 0 | 4 |
_aHLA-DR Antigens _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-6 _xanalysis |
650 | 0 | 4 |
_aInterleukin-8 _xanalysis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aOphthalmic Solutions |
650 | 0 | 4 |
_aPreservatives, Pharmaceutical _xpharmacology |
650 | 0 | 4 |
_aProstaglandins _xadministration & dosage |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aBlondin, C | |
700 | 1 | _aBaudouin, C | |
700 | 1 | _aHamard, P | |
700 | 1 | _aSabeh Afaki, G | |
700 | 1 | _aCreuzot-Garcher, C | |
700 | 1 | _aWarnet, J-M | |
700 | 1 | _aBrignole-Baudouin, F | |
773 | 0 |
_tJournal francais d'ophtalmologie _gvol. 26 _gno. 8 _gp. 782-9 |
|
999 |
_c14327559 _d14327559 |